SUZUKI, MASAKO
 Distribuzione geografica
Continente #
NA - Nord America 119
EU - Europa 93
AS - Asia 58
AF - Africa 3
SA - Sud America 1
Totale 274
Nazione #
US - Stati Uniti d'America 118
SG - Singapore 26
IT - Italia 21
CN - Cina 20
GB - Regno Unito 20
DE - Germania 17
SE - Svezia 16
IN - India 7
IE - Irlanda 5
FR - Francia 4
JO - Giordania 3
TG - Togo 3
AT - Austria 2
UA - Ucraina 2
BG - Bulgaria 1
CA - Canada 1
CL - Cile 1
EE - Estonia 1
FI - Finlandia 1
GR - Grecia 1
NL - Olanda 1
PH - Filippine 1
RU - Federazione Russa 1
TH - Thailandia 1
Totale 274
Città #
Singapore 25
Southend 19
Santa Clara 14
Chandler 12
Wilmington 11
Houston 10
Comano 8
Fairfield 8
Princeton 6
Dublin 5
Frankfurt am Main 5
Ashburn 4
Bologna 4
Nanjing 4
Seattle 4
Amman 3
Boardman 3
Lomé 3
Redwood City 3
Turin 3
Westminster 3
Beijing 2
Berlin 2
Cambridge 2
Des Moines 2
Jinan 2
Lohne 2
Naples 2
Redmond 2
Shenyang 2
Woodbridge 2
Bengaluru 1
Changsha 1
Haikou 1
Helsinki 1
Jinhua 1
London 1
Los Angeles 1
Nanchang 1
Ningbo 1
Norwalk 1
Olalla 1
Padova 1
Parsippany 1
Taiyuan 1
Tianjin 1
Toronto 1
Zhengzhou 1
Totale 194
Nome #
Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease. 138
Pembrolizumab plus lenalidomide and dexamethasone for patients with treatment-naive multiple myeloma (KEYNOTE-185): a randomised, open-label, phase 3 trial 80
Pembrolizumab plus pomalidomide and dexamethasone for patients with relapsed or refractory multiple myeloma (KEYNOTE-183): a randomised, open-label, phase 3 trial 64
Totale 282
Categoria #
all - tutte 878
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 878


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202042 0 0 0 0 0 0 4 10 11 11 6 0
2020/202134 8 0 2 0 1 10 2 0 1 0 4 6
2021/202238 0 3 3 0 9 2 0 4 0 2 7 8
2022/202366 9 12 4 6 6 5 2 4 12 0 5 1
2023/202416 1 7 2 1 1 1 0 1 0 1 0 1
2024/202561 6 22 3 6 17 5 2 0 0 0 0 0
Totale 282